ViroPharma is a biopharmaceutical company focused on the development and commercialization of therapies for rare diseases. The company primarily serves healthcare professionals and patients who are affected by these rare conditions. Operating in the niche market of rare disease treatment, ViroPharma leverages its expertise in biotechnology to create innovative solutions that address unmet medical needs. The business model revolves around extensive research and development (R&D) to bring new therapies to market, followed by commercialization efforts to ensure these therapies reach the patients who need them. Revenue is generated through the sale of these specialized therapies, often supported by partnerships and collaborations with other healthcare entities. The company aims to improve patient outcomes and quality of life through its targeted therapeutic offerings.

Keywords: biopharmaceutical, rare diseases, therapies, patient care, biotechnology, R&D, commercialization, healthcare professionals, innovative solutions, partnerships.